Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Titel:
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Auteur:
Dearnaley, David Syndikus, Isabel Mossop, Helen Khoo, Vincent Birtle, Alison Bloomfield, David Graham, John Kirkbride, Peter Logue, John Malik, Zafar Money-Kyrle, Julian O'Sullivan, Joe M Panades, Miguel Parker, Chris Patterson, Helen Scrase, Christopher Staffurth, John Stockdale, Andrew Tremlett, Jean Bidmead, Margaret Mayles, Helen Naismith, Olivia South, Chris Gao, Annie Cruickshank, Clare Hassan, Shama Pugh, Julia Griffin, Clare Hall, Emma
Verschenen in:
Lancet oncology
Paginering:
Jaargang 17 (2016) nr. 8 pagina's 14 p.
Jaar:
2016
Inhoud:
Uitgever:
Dearnaley et al. Open Access article distributed under the terms of CC BY